Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

Nature Genetics

Volumn 45, Issue 6, 2013, Pages 670-675

  Liu, Jimmy Z ^a   Hov, Johannes Roksund ^b,c   Folseraas, Trine ^b,c   Ellinghaus, Eva ^d   Rushbrook, Simon M ^e   Doncheva, Nadezhda T ^f   Andreassen, Ole A ^c,g   Weersma, Rinse K ^h   Weismüller, Tobias J ^i,bp   Eksteen, Bertus ^j   Invernizzi, Pietro ^k   Hirschfield, Gideon M ^l,m   Gotthardt, Daniel Nils ⁿ   Pares, Albert ^o   Ellinghaus, David ^d   Shah, Tejas ^a   Juran, Brian D ^p   Milkiewicz, Piotr ^q   Rust, Christian ^r   Schramm, Christoph ^s   Muler, Tobias ^t   Srivastava, Brijesh ^u   Dalekos, Georgios ^v   Nöthen, Markus M ^w   Herms, Stefan ^w   Winkelmann, Juliane ^x,y   Mitrovic, Mitja ^h   Braun, Felix ^z   Ponsioen, Cyriel Y ^aa   Croucher, Peter J P ^ab   Sterneck, Martina ^s   Teufel, Andreas ^ac   Andrew L Mason, ^ad   Saarela, Janna ^ae   Leppa, Virpi ^ae   Dorfman, Ruslan ^af   Alvaro, Domenico ^ag   Floreani, Annarosa ^ah   Onengut Gumuscu, Suna ^ai,aj   Rich, Stephen S ^ai,aj   Thompson, Wesley K ^ak   Schork, Andrew J ^al   Næss, Sigrid ^b,c   Thomsen, Ingo ^d   Mayr, Gabriele ^f   König, Inke R ^am   Hveem, Kristian ^an   Cleynen, Isabelle ^a,ao   Gutierrez Achury, Javier ^h   Ricaño Ponce, Isis ^h   Van Heel, David ^ap   Björnsson, Einar ^aq   Sandford, Richard N ^u   Durie, Peter R ^ar   Melum, Espen ^b,c   Vatn, Morten H ^b,c,as   Silverberg, Mark S ^at   Duerr, Richard H ^au,av   Padyukov, Leonid ^aw   Brand, Stephan ^ax   Sans, Miquel ^ay   Annese, Vito ^az,ba   Achkar, Jean Paul ^bb   Boberg, Kirsten Muri ^b,c   Marschall, Hanns Ulrich ^bc   Chazouillères, Olivier ^bd   Bowlus, Christopher L ^be   Wijmenga, Cisca ^h   Schrumpf, Erik ^b,c   Vermeire, Severine ^ao,bf   Albrecht, Mario ^f,bg   Rioux, John D ^bh,bi   Alexander, Graeme ^u   Bergquist, Annika ^aw   Cho, Judy ^bj   Schreiber, Stefan ^d   Manns, Michael P ⁱ   Färkkilä, Martti ^bk   Dale, Anders M ^bl,bm   Chapman, Roger W ^bn   Konstantinos N Lazaridis, ^p   Franke, Andre ^d   Anderson, Carl A ^a   Karlsen, Tom H ^b,bo   more..

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF KIEL   (Germany)

^e NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^f MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j University of Calgary and Alberta Health Services   (Canada)

^k HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^l UNIVERSITY OF TORONTO   (Canada)

^m University of Birmingham   (United Kingdom)

ⁿ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^o UNIVERSITY OF BARCELONA   (Spain)

^p MAYO CLINIC   (United States)

^q POMERANIAN MEDICAL UNIVERSITY   (Poland)

^r UNIVERSITY OF MUNICH   (Germany)

^s UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^t CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^u UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^v UNIVERSITY OF THESSALY   (Greece)

^w UNIVERSITY OF BONN   (Germany)

^x TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^y INSTITUTE OF EPIDEMIOLOGY   (Germany)

^z UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^aa ACADEMIC MEDICAL CENTER   (Netherlands)

^ab UNIVERSITY OF CALIFORNIA   (United States)

^ac JOHANNES GUTENBERG UNIVERSITY   (Germany)

^ad UNIVERSITY OF ALBERTA   (Canada)

^ae UNIVERSITY OF HELSINKI   (Finland)

^af HOSPITAL FOR SICK CHILDREN   (Canada)

^ag SAPIENZA UNIVERSITY OF ROME   (Italy)

^ah UNIVERSITY OF PADOVA   (Italy)

^ai UNIVERSITY OF VIRGINIA   (United States)

^aj UNIVERSITY OF VIRGINIA   (United States)

^ak UNIVERSITY OF CALIFORNIA   (United States)

^al UNIVERSITY OF CALIFORNIA   (United States)

^am UNIVERSITY OF LÜBECK   (Germany)

^an NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^ao UNIVERSITY OF LEUVEN   (Belgium)

^ap QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^aq LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ar HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^as AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^at MOUNT SINAI HOSPITAL   (Canada)

^au UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^av UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^aw KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ax LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^ay CENTRO MÉDICO TEKNON   (Spain)

^az CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^ba CAREGGI UNIVERSITY HOSPITAL   (Italy)

^bb LERNER RESEARCH INSTITUTE   (United States)

^bc SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^bd HÔPITAL SAINT ANTOINE   (France)

^be UNIVERSITY OF CALIFORNIA   (United States)

^bf UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^bg UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^bh UNIVERSITÉ DE MONTRÉAL   (Canada)

^bi MONTREAL HEART INSTITUTE   (Canada)

^bj YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bk HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^bl UNIVERSITY OF CALIFORNIA   (United States)

^bm UNIVERSITY OF CALIFORNIA   (United States)

^bn JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^bo UNIVERSITY OF BERGEN   (Norway)

^bp UNIVERSITY HOSPITAL BONN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; COMORBIDITY; COMPARATIVE STUDY; ENTERITIS; EUROPE; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PLEIOTROPY; POPULATION DYNAMICS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR;

CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; GENE FREQUENCY; GENETIC LOCI; GENETIC PLEIOTROPY; GENOME-WIDE ASSOCIATION STUDY; GENOTYPING TECHNIQUES; HUMANS; LINKAGE DISEQUILIBRIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84878725018     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2616     Document Type: Article

References (58)

1. Aadland, E. et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand. J. Gastroenterol. 22, 655-664 (1987).
2. Broomé, U. et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38, 610-615 (1996).
3. Farrant, J.M. et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 100, 1710-1717 (1991).
4. Cortes, A. & Brown, M.A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).
5. Karlsen, T.H., Schrumpf, E. & Boberg, K.M. Update on primary sclerosing cholangitis. Dig. Liver Dis. 42, 390-400 (2010).
6. Karlsen, T.H. & Kaser, A. Deciphering the genetic predisposition to primary sclerosing cholangitis. Semin. Liver Dis. 31, 188-207 (2011).
7. Saarinen, S., Olerup, O. & Broome, U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 95, 3195-3199 (2000).
8. Bergquist, A. et al. Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis. Clin. Gastroenterol. Hepatol. 6, 939-943 (2008).
9. Karlsen, T.H. et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology 138, 1102-1111 (2010).
10. Srivastava, B. et al. Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scand. J. Gastroenterol. 47, 820-826 (2012).
11. Folseraas, T. et al. Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J. Hepatol. 57, 366-375 (2012).
12. Melum, E. et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat. Genet. 43, 17-19 (2011).
13. Ellinghaus, D. et al. Genome-wide association analysis in sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology published online; doi:10.1002/hep.25977 (23 July 2012).
14. Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193-1201 (2011).
15. Pirinen, M., Donnelly, P. & Spencer, C. Efficient computation with a linear mixed model on large-scale data sets with applications to genetic studies. Ann. Appl. Stat. 7, 369-390 (2013).
16. Cordell, H.J. & Clayton, D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 70, 124-141 (2002).
17. Peters, U. et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum. Genet. 131, 217-234 (2012).
18. Gerstein, M.B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91-100 (2012).
19. Rossin, E.J. et al. Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet. 7, e1001273 (2011).
20. Raychaudhuri, S. et al. Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet. 5, e1000534 (2009).
21. Hanna, R.N. et al. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 12, 778-785 (2011).
22. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
23. Kasler, H.G. et al. Histone deacetylase 7 regulates cell survival and TCR signaling in CD4/CD8 double-positive thymocytes. J. Immunol. 186, 4782-4793 (2011).
24. Dequiedt, F. et al. HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. Immunity 18, 687-698 (2003).
25. Dequiedt, F. et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 201, 793-804 (2005).
26. Clark, K. et al. Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages. Proc. Natl. Acad. Sci. USA 109, 16986-16991 (2012).
27. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291-296 (2012).
28. Schrumpf, E. et al. HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. Scand. J. Gastroenterol. 17, 187-191 (1982).
29. Spurkland, A. et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53, 459-469 (1999).
30. Stokkers, P.C., Reitsma, P.H., Tytgat, G.N. & van Deventer, S.J. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 45, 395-401 (1999).
31. Okada, Y. et al. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. Gastroenterology 141, 864-871.e1-5 (2011).
32. Horton, R. et al. Gene map of the extended human MHC. Nat. Rev. Genet. 5, 889-899 (2004).
33. Hov, J.R. et al. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology 53, 1967-1976 (2011).
34. Hovhannisyan, Z. et al. The role of HLA-DQ8 β57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature 456, 534-538 (2008).
35. Broomé, U. & Bergquist, A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin. Liver Dis. 26, 31-41 (2006).
36. CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013).
37. Zhernakova, A., van Diemen, C.C. & Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10, 43-55 (2009).
38. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289-300 (1995).
39. Storey, J.D. The positive false discovery rate: a Bayesian interpretation and the q-value. Ann. Stat. 31, 2013-2035 (2003).
40. Efron, B. Simultaneous inference: when should hypothesis testing problems be combined? Ann. Appl. Statist. 2, 197-223 (2008).
41. Sun, L., Craiu, R.V., Paterson, A.D. & Bull, S.B. Stratified false discovery control for large-scale hypothesis testing with application to genome-wide association studies. Genet. Epidemiol. 30, 519-530 (2006).
42. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
43. Bellenguez, C., Strange, A., Freeman, C., Donnelly, P. & Spencer, C.C. A robust clustering algorithm for identifying problematic samples in genome-wide association studies. Bioinformatics 28, 134-135 (2012).
44. Patterson, N., Price, A.L. & Reich, D. Population structure and eigenanalysis. PLoS Genet. 2, e190 (2006).
45. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
46. Liu, J.Z. et al. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 44, 1137-1141 (2012).
47. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
48. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011).
49. Korte, A. et al. A mixed-model approach for genome-wide association studies of correlated traits in structured populations. Nat. Genet. 44, 1066-1071 (2012).
50. Tsoi, L.C. et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat. Genet. 44, 1341-1348 (2012).
51. Morris, J.A., Randall, J.C., Maller, J.B. & Barrett, J.C. Evoker: a visualization tool for genotype intensity data. Bioinformatics 26, 1786-1787 (2010).
52. DeLong, E.R., DeLong, D.M. & Clarke-Pearson, D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837-845 (1988).
53. Schlicker, A., Domingues, F.S., Rahnenfuhrer, J. & Lengauer, T. A new measure for functional similarity of gene products based on Gene Ontology. BMC Bioinformatics 7, 302 (2006).
54. Schlicker, A. & Albrecht, M. FunSimMat update: new features for exploring functional similarity. Nucleic Acids Res. 38, D244-D248 (2010).
55. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498-2504 (2003).
56. Efron, B. Size, power and false discovery rates. Ann. Stat. 35, 1351-1377 (2007).
57. Yoo, Y.J., Pinnaduwage, D., Waggott, D., Bull, S.B. & Sun, L. Genome-wide association analyses of North American Rheumatoid Arthritis Consortium and Framingham Heart Study data utilizing genome-wide linkage results. BMC Proc. 3 (suppl. 7), S103 (2009).
58. So, H.C., Gui, A.H., Cherny, S.S. & Sham, P.C. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet. Epidemiol. 35, 310-317 (2011).